VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis

PLoS Pathogens

Volumn 4, Issue 9, 2008, Pages

  Stanley, Amanda C ^a   Dalton, Jane E ^b   Rossotti, Susanna H ^a   MacDonald, Kelli P ^a   Zhou, Yonghong ^a   Rivera, Fabian ^a   Schroder, Wayne A ^a   Maroof, Asher ^b   Hill, Geoff R ^a   Kaye, Paul M ^b   Engwerda, Christian R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12P40; MESSENGER RNA; NITRIC OXIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1 ANTIBODY; VERY LATE ACTIVATION ANTIGEN 4; PROTOZOON ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; LEISHMANIA DONOVANI; LEUKOCYTE; LIVER; MICROBIAL GROWTH; MOUSE; NONHUMAN; PROTEIN INTERACTION; SPLEEN; T LYMPHOCYTE ACTIVATION; VISCERAL LEISHMANIASIS; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE STRAIN; PARASITOLOGY;

LEISHMANIA DONOVANI;

ANIMALS; ANTIBODIES, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; INTEGRIN ALPHA4BETA1; INTERLEUKIN-12 SUBUNIT P40; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; SPLEEN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 53049092307     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000158     Document Type: Article

References (32)

1. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, et al. (1995) The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 128: 1243-1253.
2. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, et al. (1995) alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80: 413-422.
3. Lo CG, Lu TT, Cyster JG (2003) Integrin-dependence of lymphocyte entry into the splenic white pulp. J Exp Med 197: 353-361.
4. Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ (2001) Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98: 1289-1297.
5. Koopman G, Parmentier HK, Schuurman HJ, Newman W, Meijer CJ, et al. (1991) Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J Exp Med 173: 1297-1304.
6. Carrasco YR, Batista FD (2006) B-cell activation by membrane-bound antigens is facilitated by the interaction of VLA-4 with VCAM-1. Embo J 25: 889-899.
7. Mittelbrunn M, Molina A, Escribese MM, Yanez-Mo M, Escudero E, et al. (2004) VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses. Proc Natl Acad Sci U S A 101: 11058-11063.
8. Engwerda CR, Kaye PM (2000) Organ-specific immune responses associated with infectious disease. Immunol Today 21: 73-78.
9. Murray HW, Squires KE, Miralles CD, Stoeckle MY, Granger AM, et al. (1992) Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J Immunol 148: 1858-1863.
10. Murray HW, Nathan CF (1999) Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189: 741-746.
11. Murray HW, Jungbluth A, Ritter E, Montelibano C, Marino MW (2000) Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect Immun 68: 6289-6293.
12. Engwerda CR, Ato M, Cotterell SE, Mynott TL, Tschannerl A, et al. (2002) A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. Am J Pathol 161: 429-437.
13. Ato M, Stager S, Engwerda CR, Kaye PM (2002) Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol 3: 1185-1191.
14. Murray HW (1997) Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. J Infect Dis 175: 1477-1479.
15. Gorak PM, Engwerda CR, Kaye PM (1998) Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol 28: 687-695.
16. Engwerda CR, Murphy ML, Cotterell SE, Smelt SC, Kaye PM (1998) Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur J Immunol 28: 669-680.
17. Engwerda CR, Ato M, Stager S, Alexander CE, Stanley AC, et al. (2004) Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am J Pathol 165: 2123-2133.
18. Ato M, Maroof A, Zubairi S, Nakano H, Kakiuchi T, et al. (2006) Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21. J Immunol 176: 5486-5493.
19. Lu TT, Cyster JG (2002) Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297: 409-412.
20. Mackay F, Browning JL (1998) Turning off follicular dendritic cells. Nature 395: 26-27.
21. Kraal G (1992) Cells in the marginal zone of the spleen. Int Rev Cytol 132: 31-74.
22. Anderson CF, Lucas M, Gutierrez-Kobeh L, Field AE, Mosser DM (2004) T cell biasing by activated dendritic cells. J Immunol 173: 955-961.
23. Drechsler Y, Chavan S, Catalano D, Mandrekar P, Szabo G (2002) FcgammaR cross-linking mediates NF-kappaB activation, reduced antigen presentation capacity, and decreased IL-12 production in monocytes without modulation of myeloid dendritic cell development. J Leukoc Biol 72: 657-667.
24. Morris TA, Marsh JJ, Chiles PG, Konopka RG, Pedersen CA, et al. (2004) Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer. Am J Respir Crit Care Med 169: 987-993.
25. Macfarlane DJ, Smart RC, Tsui WW, Gerometta M, Eisenberg PR, et al. (2006) Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab9. Eur J Nucl Med Mol Imaging 33: 648-656.
26. Murray HW, Tsai CW, Liu J, Ma X (2006) Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18. Infect Immun 74: 4370-4374.
27. Maroof A, Kaye PM (2007) Temporal regulation of IL-12p70 and IL-12-related cytokines in splenic DC subsets during Leishmania donovani infection. Infect Immun.
28. Smelt SC, Engwerda CR, McCrossen M, Kaye PM (1997) Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J Immunol 158: 3813-3821.
29. Miyake K, Medina K, Ishihara K, Kimoto M, Auerbach R, et al. (1991) A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol 114: 557-565.
30. Miyake K, Weissman IL, Greenberger JS, Kincade PW (1991) Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med 173: 599-607.
31. Carter RA, Campbell IK, O'Donnel KL, Wicks IP (2002) Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking. Clin Exp Immunol 128: 44-51.
32. Murphy ML, Cotterell SE, Gorak PM, Engwerda CR, Kaye PM (1998) Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J Immunol 161: 4153-4160.